1. | pinkiemeck | |
2. | buzzandbuzzhead |
1. | pinkiemeck | |
2. | buzzandbuzzhead |
1. | pinkiemeck 03/09/2018 Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic, O… |
2. | buzzandbuzzhead 03/09/2018 Beats EPS loss estimates by $0.20 |
3. | pinkiemeck 02/14/2018 MyoKardia Begins Patient Dosing in Phase 1b Clinical Study of MYK-491 in Dilated Cardiomyopathy Patients |